SBC Medical Group Holdings Incorporated Financing Cash Flow
SBC Medical Group Holdings Incorporated (SBC) reported Financing Cash Flow of -$3.80 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-13
- SBC Medical Group Holdings Incorporated net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was -$1.96M, a 127.30% decline year-over-year.
- SBC Medical Group Holdings Incorporated net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$1.84M.
- SBC Medical Group Holdings Incorporated net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $19.82M, a 74.16% increase year-over-year.
- SBC Medical Group Holdings Incorporated net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $11.57M, a 1.07% decline year-over-year.
- SBC Medical Group Holdings Incorporated net cash provided by (used in) financing activities for fiscal 2025 was $38.29M, a 66.74% increase from fiscal 2024.
- SBC Medical Group Holdings Incorporated net cash provided by (used in) financing activities for fiscal 2024 was $22.97M, a 274.31% increase from fiscal 2023.
- SBC Medical Group Holdings Incorporated net cash provided by (used in) financing activities for fiscal 2023 was $6.14M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 3 month as first filed | Net Cash Provided by (Used in) Financing Activities 4 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 7 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 10 month | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$3.80M 10-Q · filed 2026-08-13 | $16.02M derived: sum of 3 quarters · filed 2026-08-13 | $27.59M derived: sum of 4 quarters · filed 2026-08-13 | |||||||
| 2026-03-31 | -$1.84M 10-Q · filed 2026-05-14 | $17.98M derived: sum of 2 quarters · filed 2026-05-14 | $29.55M derived: sum of 3 quarters · filed 2026-05-14 | $36.73M derived: sum of 4 quarters · filed 2026-08-13 | |||||||
| 2025-12-31 | $19.82M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $31.39M derived: sum of 2 quarters · filed 2026-03-27 | $38.57M derived: sum of 3 quarters · filed 2026-08-13 | $38.29M 10-K · filed 2026-03-27 | |||||||
| 2025-09-30 | $11.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $18.75M derived: sum of 2 quarters · filed 2026-08-13 | $18.47M 10-Q · filed 2025-11-14 | $29.85M derived: sum of 4 quarters · filed 2026-08-13 | |||||||
| 2025-06-30 | $7.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $6.90M 10-Q · filed 2026-08-13 | $18.28M derived: sum of 3 quarters · filed 2026-08-13 | $29.98M derived: sum of 4 quarters · filed 2026-08-13 | |||||||
| 2025-03-31 | -$280.38K 10-Q · filed 2026-05-14 | $11.10M derived: sum of 2 quarters · filed 2026-05-14 | $22.79M derived: sum of 3 quarters · filed 2026-05-14 | $22.73M derived: sum of 4 quarters · filed 2026-05-14 | |||||||
| 2024-12-31 | $11.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $23.07M derived: sum of 2 quarters · filed 2026-03-27 | $23.01M derived: sum of 3 quarters · filed 2026-03-27 | $22.97M 10-K · filed 2026-03-27 | |||||||
| 2024-09-30 | $11.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $11.62M derived: sum of 2 quarters · filed 2025-11-14 | $11.58M 10-Q · filed 2025-11-14 | $11.46M derived: sum of 4 quarters · filed 2025-11-14 | |||||||
| 2024-06-30 | -$69.11K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$109.34K 10-Q · filed 2025-08-13 | -$1.26M 10-Q · filed 2024-08-16 | -$236.56K derived: sum of 3 quarters · filed 2025-08-13 | $105.10M derived: sum of 4 quarters · filed 2025-08-13 | ||||||
| 2024-03-31 | -$40.23K 10-Q · filed 2025-05-15 | -$1.26M 10-Q · filed 2024-05-20 | -$167.45K derived: sum of 2 quarters · filed 2025-05-15 | $105.17M derived: sum of 3 quarters · filed 2025-05-15 | |||||||
| 2023-12-31 | -$127.22K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $105.21M derived: sum of 2 quarters · filed 2025-03-28 | $6.14M 10-K · filed 2025-03-28 | -$99.08M 10-K · filed 2024-03-19 | |||||||
| 2023-09-30 | $105.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $6.26M 10-Q · filed 2024-11-13 | -$99.08M 10-Q · filed 2023-11-14 | ||||||||
| 2023-06-30 | -$99.08M 10-Q · filed 2024-08-16 | ||||||||||
| 2022-12-31 | $118.82M 10-K · filed 2024-03-19 | ||||||||||
| 2022-09-30 | $118.82M 10-Q · filed 2023-11-14 | ||||||||||
| 2022-06-30 | $185.19K 10-Q · filed 2023-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |
| Teladoc Health, Inc. (TDOC) | United States | $1.114B | -8.68 |